Cargando…
Aβ(8-20) Fragment as an Anti-Fibrillogenic and Neuroprotective Agent: Advancing toward Efficient Alzheimer’s Disease Treatment
[Image: see text] Alzheimer’s disease (AD) is the most common cause of dementia, characterized by a spectrum of symptoms associated with memory loss and cognitive decline with deleterious consequences in everyday life. The lack of specific drugs for the treatment and/or prevention of this pathology...
Autores principales: | Zimbone, Stefania, Giuffrida, Maria Laura, Sabatino, Giuseppina, Di Natale, Giuseppe, Tosto, Rita, Consoli, Grazia M. L., Milardi, Danilo, Pappalardo, Giuseppe, Sciacca, Michele F.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020970/ https://www.ncbi.nlm.nih.gov/pubmed/36857606 http://dx.doi.org/10.1021/acschemneuro.2c00720 |
Ejemplares similares
-
Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer’s Disease?
por: Di Natale, Giuseppe, et al.
Publicado: (2022) -
Novel Peptide-Calix[4]arene Conjugate Inhibits Aβ
Aggregation and Rescues Neurons from Aβ’s Oligomers Cytotoxicity In Vitro
por: Consoli, Grazia Maria Letizia, et al.
Publicado: (2021) -
Identification of fibrillogenic regions in human triosephosphate isomerase
por: Carcamo-Noriega, Edson N., et al.
Publicado: (2016) -
Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis
por: Berson, Joanne F., et al.
Publicado: (2003) -
Conformational Preferences of a 14-Residue Fibrillogenic Peptide from Acetylcholinesterase
por: Vijayan, Ranjit, et al.
Publicado: (2010)